Abstract:Key PointsChemokines are a subset of cytokines that cause the directed migration of leukocytes along a chemical gradient of ligand, known as the chemokine gradient. More than 50 human chemokines and 18 chemokine receptors have been discovered so far.Many cancers have a complex chemokine network that influences the immune-cell infiltration of a tumour, as well as tumour cell growth, survival and migration, and angiogenesis.Immune cells, endothelial cells and tumour cells themselves express chemokine receptors and can respond to chemokine gradients.Chemokines are a key determinant of the macrophage and lymphocyte infiltrate of human cancers and might contribute to T-helper 2 cell polarization.Malignant cells from different cancer types have different profiles of chemokine-receptor expression, but CXCR4 is most commonly found; at the last count, cells from 23 different cancer types expressed this receptor.Mutations in genes that alter levels of hypoxia-inducible factor, or gene-fusion events, can induce CXCR4 in cells that do not normally express this receptor. CXCR4 is also transiently increased by factors such as hypoxia, vascular endothelial growth factor and oestrogen in the tumour microenvironment.Studies of human cancer biopsy sampler and mouse cancer models show that cancer cell chemokine-receptor expression is associated with increased metastatic capacity.Preliminary laboratory data show that chemokine-receptor antagonists inhibit macrophage infiltrates, can induce tumour growth arrest or apoptosis, and prevent metastatic spread.Research into the cancer chemokine network is revealing parallels between the pathology of inflammation and malignancy, parallels that enhance our understanding of both types of disease and indicate new approaches for treatment.

Role and significance of chemokine-binding proteins in tumor

The relationship between chemokines and breast cancer

Chemokines and their role in tumor growth and metastasis

Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.

Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy

Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer

The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment

The Perspective of Chemokine and Its Receptor in Tumor Therapy

Chemokines and chemokine receptors: A new strategy for breast cancer therapy

Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers

The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment

Role of chemokines in the crosstalk between tumor and tumor-associated macrophages

Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy

Cancer and the chemokine network

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

The functional roles of chemokines and chemokine receptors in colorectal cancer progression

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma

Coexpression And Synergistic Role Of Multiple Atypical Chemokine Binders In Breast Cancer

Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis